Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 293

1.

New drugs for the treatment of attention-deficit/hyperactivity disorder.

Pataki CS, Feinberg DT, McGough JJ.

Expert Opin Emerg Drugs. 2004 Nov;9(2):293-302. Review.

PMID:
15571486
2.

New drugs for treatment of attention-deficit/hyperactivity disorder.

Chung B, Suzuki AR, McGough JJ.

Expert Opin Emerg Drugs. 2002 Oct;7(2):269-76.

PMID:
15989550
3.

Pharmacological management of attention-deficit hyperactivity disorder.

Reeves G, Schweitzer J.

Expert Opin Pharmacother. 2004 Jun;5(6):1313-20. Review.

PMID:
15163276
4.

Drugs under investigation for attention-deficit hyperactivity disorder.

Schweitzer JB, Holcomb HH.

Curr Opin Investig Drugs. 2002 Aug;3(8):1207-11. Review.

PMID:
12211416
5.

Attention-deficit-hyperactivity disorder: an update.

Dopheide JA, Pliszka SR.

Pharmacotherapy. 2009 Jun;29(6):656-79. doi: 10.1592/phco.29.6.656. Review.

PMID:
19476419
6.

Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.

Findling RL.

Clin Ther. 2008 May;30(5):942-57. doi: 10.1016/j.clinthera.2008.05.006. Review.

PMID:
18555941
7.

ADHD: new pharmacological treatments on the horizon.

López FA.

J Dev Behav Pediatr. 2006 Oct;27(5):410-6. Review.

PMID:
17041279
8.

Pharmacological treatment of attention-deficit/hyperactivity disorder in adults.

Slatkoff J, Greenfield B.

Expert Opin Investig Drugs. 2006 Jun;15(6):649-67. Review.

PMID:
16732717
9.

Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.

Quintana H, Cherlin EA, Duesenberg DA, Bangs ME, Ramsey JL, Feldman PD, Allen AJ, Kelsey DK.

Clin Ther. 2007 Jun;29(6):1168-77.

PMID:
17692731
11.

Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents.

Garnock-Jones KP, Keating GM.

Paediatr Drugs. 2009;11(3):203-26. doi: 10.2165/00148581-200911030-00005. Review.

PMID:
19445548
13.

Treatment of attention-deficit/hyperactivity disorder: overview of the evidence.

Brown RT, Amler RW, Freeman WS, Perrin JM, Stein MT, Feldman HM, Pierce K, Wolraich ML; American Academy of Pediatrics Committee on Quality Improvement; American Academy of Pediatrics Subcommittee on Attention-Deficit/Hyperactivity Disorder.

Pediatrics. 2005 Jun;115(6):e749-57. Review.

PMID:
15930203
14.

A review of the pharmacotherapy of adults with attention-deficit/hyperactivity disorder.

Wilens TE, Spencer TJ, Biederman J.

J Atten Disord. 2002 Mar;5(4):189-202. Review.

PMID:
11967475
17.

Pharmacotherapy of adult ADHD.

Dodson WW.

J Clin Psychol. 2005 May;61(5):589-606. Review.

PMID:
15723384
18.

New options in the pharmacological management of attention-deficit/hyperactivity disorder.

Olfson M.

Am J Manag Care. 2004 Jul;10(4 Suppl):S117-24. Review.

19.

Non-stimulant treatment of attention-deficit/hyperactivity disorder.

Pliszka SR.

CNS Spectr. 2003 Apr;8(4):253-8. Review.

PMID:
12679740
20.

Present and future pharmacotherapeutic options for adult attention deficit/hyperactivity disorder.

Horrigan JP.

Expert Opin Pharmacother. 2001 Apr;2(4):573-86. Review.

PMID:
11336608

Supplemental Content

Support Center